# Bellicum Pharmaceuticals Inc. (BLCM)

Source: https://www.quantisnow.com/company/BLCM
Generated: 2026-11-11T16:13:36.856Z

- Ticker: BLCM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014
- Website: bellicum.com

## About

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes when administered after hematopoietic stem cell transplantation in the treatment of hematologic malignancies and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is based in Houston, Texas.

## Latest BLCM news and filings

- 2024-03-01 20:13 UTC [SEC Form 15-12G filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-bellicum-pharmaceuticals-inc-5309209)
- 2024-02-27 05:16 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-bellicum-pharmaceuticals-inc-5293832)
- 2024-02-27 05:18 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-bellicum-pharmaceuticals-inc-5293829)
- 2024-02-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-bellicum-pharmaceuticals-inc-5293821)
- 2024-02-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-bellicum-pharmaceuticals-inc-5293814)
- 2024-02-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-bellicum-pharmaceuticals-inc-5293801)
- 2024-02-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-bellicum-pharmaceuticals-inc-5293799)
- 2024-02-23 22:26 UTC [SEC Form 8-K] [Bellicum Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bellicum-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-financial-5289234)
- 2024-02-23 18:19 UTC [SEC Form POS AM filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-bellicum-pharmaceuticals-inc-5287789)
- 2024-02-23 18:19 UTC [SEC Form POS AM filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-bellicum-pharmaceuticals-inc-5287788)
- 2024-02-23 18:18 UTC [SEC Form POS AM filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-bellicum-pharmaceuticals-inc-5287787)
- 2024-02-23 18:18 UTC [SEC Form POS AM filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-bellicum-pharmaceuticals-inc-5287786)
- 2024-02-23 18:17 UTC [SEC Form POS AM filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-bellicum-pharmaceuticals-inc-5287784)
- 2024-02-23 18:17 UTC [SEC Form POS AM filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-bellicum-pharmaceuticals-inc-5287783)
- 2024-02-23 18:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287782)
- 2024-02-23 18:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287781)
- 2024-02-23 18:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287779)
- 2024-02-23 18:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287778)
- 2024-02-23 18:15 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287777)
- 2024-02-23 18:15 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287775)
- 2024-02-23 18:15 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287773)
- 2024-02-23 18:14 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287769)
- 2024-02-23 18:14 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287768)
- 2024-02-23 18:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287767)
- 2024-02-23 18:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287766)
- 2024-02-23 18:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287765)
- 2024-02-23 18:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellicum-pharmaceuticals-inc-5287764)
- 2024-02-21 21:07 UTC [SEC Form 8-K] [Bellicum Pharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bellicum-pharmaceuticals-inc-filed-sec-form-8-k-completion-of-acquisition-5279871)
- 2024-02-14 23:00 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Bellicum Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-bellicum-pharmaceuticals-inc-amendment-5265332)
- 2024-02-14 19:23 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Bellicum Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-bellicum-pharmaceuticals-inc-amendment-5262044)
- 2024-01-30 21:00 UTC [SEC Form 8-K] [Bellicum Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bellicum-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-5217190)
- 2024-01-24 21:00 UTC [SEC Form 8-K] [Bellicum Pharmaceuticals Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bellicum-pharmaceuticals-inc-filed-sec-form-8-k-unregistered-sales-of-5204718)
- 2023-12-14 21:30 UTC [SEC Form 8-K] [Bellicum Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bellicum-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5138655)
- 2023-11-24 18:43 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Bellicum Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-bellicum-pharmaceuticals-inc-amendment-5102687)
- 2023-11-24 18:39 UTC [SEC Form 4] [Baker Bros. Advisors Lp exercised 2,116,349 in-the-money shares at a strike of $0.00 (SEC Form 4)](https://www.quantisnow.com/insight/baker-bros-advisors-lp-exercised-2116349-in-the-money-shares-at-a-5102684)
- 2023-11-22 13:26 UTC [SEC Form 8-K] [Bellicum Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bellicum-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5100235)
- 2023-11-14 21:24 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bellicum-pharmaceuticals-inc-5085171)
- 2023-09-29 17:13 UTC [SEC Form 8-K] [Bellicum Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bellicum-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-financial-4994718)
- 2023-08-10 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bellicum-pharmaceuticals-inc-4879489)
- 2023-07-10 10:06 UTC [SEC Form 25-NSE filed by Bellicum Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-bellicum-pharmaceuticals-inc-4733544)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BLCM
- Earnings history: https://www.quantisnow.com/earnings/BLCM
- Dividend history: https://www.quantisnow.com/dividends/BLCM
- Insider transactions: https://www.quantisnow.com/insiders/BLCM
- Options chain: https://www.quantisnow.com/options/BLCM
- SEC 8-K filings only: https://www.quantisnow.com/company/BLCM/8-k
- RSS and alerts for BLCM: https://www.quantisnow.com/docs/rss-feeds.md